{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:25:42Z","timestamp":1778149542227,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.adro.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T01:30:10Z","timestamp":1504143010000},"page":"57-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report"],"prefix":"10.1016","volume":"3","author":[{"given":"Jaden D.","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chase C.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew K.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2017.08.012_bib0010","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-5347(01)62763-0","article-title":"Advanced transitional cell carcinoma of the upper urinary tract: Patterns of failure, survival and impact of postoperative adjuvant radiotherapy","volume":"160","author":"Hall","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2017.08.012_bib0015","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/1097-0142(197506)35:6<1626::AID-CNCR2820350623>3.0.CO;2-C","article-title":"Primary carcinoma of the ureter: A prognostic study","volume":"35","author":"Batata","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2017.08.012_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1078-1439(96)00095-6","article-title":"Transitional cell carcinoma of the renal pelvis and ureter: Outcome and patterns of relapse in patients treated with postoperative radiation","volume":"2","author":"Catton","year":"1996","journal-title":"Urol Oncol"},{"key":"10.1016\/j.adro.2017.08.012_bib0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-11-297","article-title":"Radiotherapy may improve overall survival of patients with T3\/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.adro.2017.08.012_bib0030","first-page":"S36","article-title":"Urothelial neoplasms of the kidney and ureter. An epidemiologic, pathologic, and clinical review","volume":"117","author":"Genega","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.adro.2017.08.012_bib0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 Update","volume":"68","author":"Roupret","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2017.08.012_bib0040","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jama.1957.02970450010004","article-title":"Primary tumors of the ureter","volume":"163","author":"Twinem","year":"1957","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.adro.2017.08.012_bib0045","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.adro.2017.08.012_bib0050","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2017.08.012_bib0055","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2017.08.012_bib0060","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0022-5347(17)49328-1","article-title":"The postoperative irradiation of transitional cell carcinoma of the renal pelvis and ureter","volume":"133","author":"Brookland","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2017.08.012_bib0065","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0360-3016(92)90723-U","article-title":"Adjuvant radiotherapy in high stage transitional cell carcinoma of the renal pelvis and ureter","volume":"24","author":"Cozad","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.08.012_bib0070","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.ejso.2016.08.008","article-title":"A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma","volume":"42","author":"Fang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.adro.2017.08.012_bib0075","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0959-8049(99)00012-X","article-title":"Prognostic factors in urothelial renal pelvis and ureter tumours: A multicentre Rare Cancer Network study","volume":"35","author":"Ozsahin","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2017.08.012_bib0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000343729","article-title":"Patterns of failure and prognostic factors for locoregional recurrence after radical surgery in upper urinary tract transitional cell carcinoma: Implications for adjuvant radiotherapy","volume":"90","author":"Jang","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.adro.2017.08.012_bib0085","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/01.ju.0000137910.38441.8a","article-title":"Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter","volume":"172","author":"Czito","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2017.08.012_bib0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jama.1941.02820020032008","article-title":"Primary epithelioma of the ureter","volume":"116","author":"Cook","year":"1941","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2017.08.012_bib0095","first-page":"247","article-title":"Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: Experience in a single institution","volume":"35","author":"Fan","year":"2012","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.adro.2017.08.012_bib0100","author":"ASTRO"},{"key":"10.1016\/j.adro.2017.08.012_bib0105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":"Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.08.012_bib0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2017.08.012_bib0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrclinonc.2009.188","article-title":"Stereotactic body radiation therapy: A novel treatment modality","volume":"7","author":"Lo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.adro.2017.08.012_bib0120","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1111\/j.1464-410X.2012.11550.x","article-title":"A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma","volume":"110","author":"Siva","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2017.08.012_bib0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ijrobp.2014.07.043","article-title":"Stereotactic ablative body radiation therapy for primary kidney cancer: A 3-dimensional conformal technique associated with low rates of early toxicity","volume":"90","author":"Pham","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2017.08.012_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.radonc.2015.08.030","article-title":"Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma","volume":"117","author":"Ponsky","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2017.08.012_bib0135","first-page":"519897","article-title":"Stereotactic body radiotherapy for localized ureter ransitional cell carcinoma: Three case reports","volume":"2015","author":"Maehata","year":"2015","journal-title":"Case Rep Urol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109417301793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109417301793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:34:36Z","timestamp":1762529676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109417301793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2452109417301793"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2017.08.012","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiation therapy for medically inoperable, clinically localized, urothelial carcinoma of the renal pelvis: A case report","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}